Tag Archives: Oral

Horizon Pharma plc Announces FDA Approval to Expand the Age Range for Ravicti (glycerol phenylbutyrate) Oral Liquid to Include Newborns

Print this page DUBLIN–(BUSINESS WIRE)–Dec. 27, 2018– Horizon Pharma plc (NASDAQ: HZNP) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) to expand the age range for Ravicti (glycerol phenylbutyrate) Oral Liquid to include infants younger than two months of age living with a urea cycle disorder… Read More »

Oral Appliance Therapy – All You Ought to Know

Obstructive sleep apnea is a sleep disorder where a person stops breathing periodically due to collapsing soft tissue in the airway throughout the night. These stops in breathing usually last for around ten seconds and are often followed by snorts, gasps, or choking sounds as a person’s body fights to resume breathing again. The obstructive… Read More »